Pharmaceutical corporations and access to drugs: The "fourth wave" of corporate human rights scrutiny

Human Rights Quarterly

Volumn 25, Issue 2, 2003, Pages 425-452

  Joseph, Sarah ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRESCRIBING; HUMAN RIGHTS; INTELLECTUAL PROPERTY RIGHTS; MEDICINE;

EID: 0038658731     PISSN: 02750392     EISSN: None     Source Type: Journal    
DOI: 10.1353/hrq.2003.0018     Document Type: Article

References (77)

1. PETER MUCHLINSKI, MULTINATIONAL ENTERPRISES AND THE LAW 7 n. 19 (1995).
2. The Campaign to Label Genetically Engineered Foods, available at http://www.thecampaign.org
3. UNAIDS, AIDS Epidemic Update, available at http://www.unaids.org/epidemic_update/report_dec01/index.html#full
4. UNAIDS, Table of Country-Specific HIV/AIDS Estimates and Data, end 2001, in World Health Organization, Report on the Global HIV/AIDS Epidemic, 2001, available at http://www.who.int/hiv/pub/epidemiology/pubepidemic2002/en/
5. Tina Rosenberg, Look at Brazil, N.Y. TIMES MAG., 28 Jan. 2001, at 26.
6. UN General Assembly Declaration of Commitment on HIV/AIDS ¶¶ 24-25 (2 Aug. 2001)
7. James Thou Gathii, Construing Intellectual Property Rights and Competition Policy Consistency with Facilitating Access to Affordable AIDS Drugs to Low-End Consumers, 53 FLA. L. REV. 727, 734 (2001).
8. Anna-Marie Tabor, Recent Development: AIDS Crisis, 38 HARV. J. ON LEGIS. 514, 525 (2001).
9. JAMES BRAITHWAITE & PETER DRAHOS, GLOBAL BUSINESS REGULATION 373 (2000).
10. JEFFREY ROBINSON, PRESCRIPTION GAMES 25 (2001).
11. Jon Jeter, South Africa Resists Call for AIDS Emergency, WASH. POST, 15 Mar. 2001.
12. Diane Kroeger May, Pharmaceutical Crisis in India: Transcending Profits with Human Rights, 10 WIS. INT'L L.J. 40 (1992)
13. http://www.wto.org/english/tratop_e/dispu_e/dispu_e.htm
14. Sue Ann Mota, TRIPS-Five Years of Disputes at the WTO, 7 ARIZ. J. INT'L & COMP. L. 551, 552-53, 540-44 (2000).
15. Philippe Cullet, Patents Bill, TRIPS and Right to Health, ECON. & POL. WKLY., 27 Oct. 2001, available at http://www.epw.org.in
16. http://www/wto/org/english/tratop_e/dispu_e/dispu_e.htm
17. Sam Ricketson, Intellectual Property and Human Rights, in COMMERCIAL LAW AND HUMAN RIGHTS 187 (Stephen Bottomley & David Kinley eds., 2002).
18. Shanker A. Singham, Competition Policy and the Stimulation of Innovation: TRIPS and the Interface Between Competition and Patent Protection in the Pharmaceutical Industry, 26 BROOK. J. INT'L L. 363, 373 (2000).
19. Marcia Ang ell, The Pharmaceutical Industry: To Whom is it Accountable?, 342 (25) NEW ENG. J. MED. 1902 (2000).
20. How the Industries Stack Up, FORTUNE, 22 June 2000
21. Frank Clemente et al., America's Other Drug Problem: A Briefing Book on the Rx Drug Debate, PUBLIC CITIZEN'S CONGRESSWATCH 33-39 (2000), available at http:// www.citizen.org
22. Merck, available at http:// www.merck.com (visited 20 Jan. 2003)
23. Pfizer, at http://www.pfizer.com (visited 20 Jan. 2003).
24. Bob Young et al., Rx RandD Myths: The Case Against Drug Industry's RandD "Scare Card," PUBLIC CITIZEN'S CONGRESSWATCH, July 2001, available at http://www.citizen.org
25. App. C thereto (National Institute of Health, NIH Contributions to Pharmaceutical Development: Case Study Analysis of the Top Selling Drugs, February 2000).
26. IAIN COCKBURN & REBECCA HENDERSON, PUBLIC-PRIVATE INTERACTION AND THE PRODUCTIVITY OF PHARMACEUTICAL RESEARCH (1997).
27. James Packard Love, Affidavit in the matter between Pharmaceutical Manufacturers' Association of South Africa and Others v. The President of the Republic of South Africa and Others, Apr. 2001 available at http:// www.tac.org.za
28. COUNCIL ON GOVERNMENTAL RELATIONS, THE BAYH-DOLE ACT: A GUIDE TO THE LAW AND IMPLEMENTING REGULATIONS (Sept. 1999), available at http://www.cogr.edu/bayh-dole.htm
29. Rachel L. Swarns, AIDS Drug Battle Deepens in Africa, N.Y. TIMES, 8 Mar. 2001, at A1.
30. Jurgen Drews & Stefan Ryser, Innovation Deficit in the Pharmaceutical Industry, 30 DRUG INFO. J. 97 (1996).
31. F.M. Scherer, The Pharmaceutical Industry and World Intellectual Property Standards, 53 VAND. L. REV. 2245 (2000).
32. Peter Drahos, The Rights to Food and Health and Intellectual Property in the Era of "Biogopolies," in COMMERCIAL LAW AND HUMAN RIGHTS 192.
33. Tom G. Palmer, Are Patents and Copyrights Morally Justified? The Philosophy of Property Rights and Ideal Objects, 13 HARV. J.L. & PUB. POL'Y 817, 849 (1990).
34. Roger E. Meiners & Robert J. Staaf, Patents, Copyright, and Trademarks: Property or Monopoly, 13 HARV. J.L. & PUB. POL'Y 911, 914 (1990).
35. Friedrich A. von Hayek, The Fatal Conceit: The Errors of Socialism (W.W. Bartley III ed., 1988)
36. Edmund W. Kitsch, Elementary and Persistent Errors in the Economic Analysis of Intellectual Property, 53 VAND. L. REV. 1727, 1729-38 (2000).
37. MÉDECINS SANS FRONTIÈRES (MSF), FATAL IMBALANCE: THE CRISIS IN RESEARCH AND DRUGS FOR NEGLECTED DISEASES (Sept. 2001).
38. http://www.accessmed-msf.org/dndi/index.asp
39. http://www.unaids.org/acc_access/
40. Barton Gellman, An Unequal Calculus of Life and Death; As Millions Perished in Pandemic, Firms Debated Access to Drugs; Players in the Debate Over Drug Availability and Pricing, WASH. POST, 27 Dec. 2000, at A1.
41. Barton Gellman, A Turning Point that Left Millions Behind: Drug Discounts Benefit Few While Protecting Pharmaceutical Companies' Profits, WASH. POST, 28 Dec. 2000, at A1.
42. Bill Brubaker, The Limits of $100 Million; Epidemic's Complexities Curb Impact of Bristol-Myers's Initiative, WASH. POST, 29 Dec. 2000, at A1.
43. Nathan Geffen, Pharmaceutical Patents, Human Rights, and the HIV/AIDS Epidemic 18(31 May 2001) available at http://www.tac.org.za (link to 'Documents', 'Research Papers', 'TAC Discussion Paper on Pharmaceutical Patents').
44. Consensus Statement of Members of the Faculty of Harvard University, Antiretroviral Treatment for AIDS in Poor Countries, Mar. 2001, 14, available at http://www.hsph. harvard.edu/hai/conferences_events/2001/consensus_aids_therapy.pdf
45. Katy Salmon, Kenya-Health: Country Facing Acute Shortages of AIDS Drugs, INTER PRESS SERV., 23 Apr. 2002.
46. William Baue, Rio + 10 series: UNAIDS Accelerating Access Initiative May Decelerate Access, 19 July 2002, available at http://www.socialfunds.com/news/print.cgi?sfArticleld= 887
47. INTERNATIONAL COUNCIL ON HUMAN RIGHTS POLICY, BEYOND VOLUNTARISM: HUMAN RIGHTS AND DEVELOPING INTERNATIONAL LEGAL OBLIGATIONS OF COMPANIES 73-76 (2002).
48. S. Jacobzone, Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals, Labour Market and Social Policy-Occasional Papers No. 40 (OECD doc. DEELSA/ELSA/WD(2000)1), 17 Apr. 2000, at 4, 9, 94.
49. Jayasgree Watal, Workshop on Differential Pricing and Financing of Essential Drugs, at 9, available at http://www.who.int/medicines/library/edm_general/who-wto-hosbjor/ wto_background_e.doc
50. Declaration on the Right to Development, U.N. GAOR, 41ST SESS., 97TH MEETING, ANNEX, ARTICLES 3(2), 3(3), 4 & 10, U.N. Doc. A/RES/41/128 (1986).
51. http://www.tac.org.za (link to 'Documents' and 'Medicines Act Court Case') (13 Mar. 2001).
52. http://www.tac.org.za/ Documents/MedicineActCourtCase/pharmace.txt (visited 20 Jan. 2003).
53. Charlotte Denny and James Meek, Drugs giants made to swallow bitter pill: Global opinion won in South Africa, but will it triumph when the US fights Brazil's cheap AIDS medicine?, GUARDIAN, 19 Apr. 2001, at 12.
54. Robert Block, Drug Makers Agree to Drop South Africa Suit, WALL ST. J., 19 Apr. 2001, at A12.
55. Nick Mathiason, The Pretoria Court Case: Drugs: Round One to Africa: Nick Mathiason explains why the pharmas gave way, and why South Africa's joy may be short-lived, OBSERVER, 22 Apr. 2001 at Business, 3.
56. Paul Teixeira, M.D., National Response to the HIV and AIDS Epidemic in Brazil, Address in Washington D.C. at the Brazilian Embassy, available at http://www. brasilemb.org/social_AIDS_pauloteixeira.shtml (Sept. 2001).
57. Brazil-Measures Affecting Patent Protection, WTO Doc. G/L/454/IP/D/23/Add.1/ WT/DS199/4 at http://www.wto.org/english/docs_e/docs_e.htm
58. Lee Myers, South Africa and U.S. End Dispute Over Drugs, N.Y. TIMES, 18 Sept. 1999, at A8.
59. John Zarocostas, U.S. drops WTO case, amidst global pressure, UP INT'L, 25 June 2001.
60. WTO News, Experts: Affordable medicines for Poor Countries are Feasible, 11 Apr. 2001, press/220, available at http://www.wto.org/english/news_e/pres01_e/pr220_e.htm
61. Ray Moynihan, Drug Access 'threatened', AUSTRALIAN FIN. REV., 9 Oct. 2001, at 16.
62. Michael Mann and Frances Williams, Stage set for clash at WTO meeting over drug patents, FIN. TIMES (LONDON), 25 Oct. 2001, at 15.
63. Executive Summary of Joint WTO/WHO conference, Høsbjør, Norway, at http://www.wto.org/english/tratop_e/trips_e/tn_hosbjor_e.htm (8-11 Apr. 2001).
64. Ed Silverman, Battered Bayer opts out of fight over Cipro patent, STAR LEDGER (NEWARK) 25 Oct. 2001; Drugs Patents, FIN. TIMES (LONDON), 29 Oct. 2001, at 24.
65. Charlotte Denny, Attack on Afghanistan: Public health: Drug company accedes to call for emergency price cut: Antibiotic deal agreed after patent moves, GUARDIAN, 25 Oct. 2001, at 4.
66. Eric Lipton and Kirk Johnson, A Nation Challenged: The Anthrax Trail, N.Y. TIMES, 26 Dec. 2001, at A1.
67. WTO News, Council approves LDC decision with additional waiver, 28 June 2002, Press/301, available at http://www.wto.org/ english/news_e/pres02_e/pr301_e.htm
68. Elisabeth Rosenthal, China Now Set to Make Copies of AIDS Drugs, N.Y. TIMES, 7 Sept. 2002, at A1.
69. Zimbabwe Lifts Import Restrictions on Drugs, UN WIRE, 29 May 2002.
70. Kenya Moves to Import, Make Cheap Drugs, UN WIRE, 2 May 2002.
71. Jean O. Lanjouw, A Patent Policy Proposal for Global Diseases, at 4, available at http://www.brook.edu/views/papers/lanjouw/20010611.htm
72. Dana Ziker, Patents & Technology: Facilitating Access of AIDS Drugs While Maintaining Strong Patent Protection, 2001 DUKE L. & TECH. REV. 42.
73. http://www.wto.org/english/tratop_e/trips_e/trips_e.htm
74. The Global Fund to Fight AIDS, Tuberculosis & Malaria at http:// www.globalfundatm.org/index.html
75. Michael Grunwald, In Echo of Apartheid Fight, Public Pushes S. Africa on AIDS, WASH. POST, 28 Jan. 2003, at A1.
76. Minister of Health v. Treatment Action Campaign, available at http://www.concourt. gov.za/date2002.html
77. Nicol Degli Innocenti & Geoff Dyer, Court victory for Aids Campaigners South African HIV Policy Government Ordered To Make Drugs Available to HIV-Positive Pregnant Women, FIN. TIMES (LONDON), 6 July 2002, at 8.